Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Circular Genomics Inc.

Circular Genomics Inc.

Series AAlbuquerque, NMBiotechnology
Facts
Year of incorporation
2021sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
2
Disclosed raised
$15.0Msum of rounds with a disclosed amount only
Named investors
3
Financing history
2 rounds
  1. Dec 1, 2025
    Series A · $15.0M (disclosed)
    Mountain Group Partners (lead)HIP Fund (participant)
    Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) · “Circular Genomics Announces Closure of $15 Million Series A Financing to Advance First-in-Class Circular RNA Platform for Early Detection of Alzheimer's Disease”
  2. Jan 11, 2024
    Form D equity offering · $8.3M (form d sold) · 9 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Circular Genomics Inc. filed Form D: $8,300,000 sold of $15,000,000, Biotechnology”
Investors on record
3 edges
People
1 officers, 5 directors
Timeline
2
  1. Dec 1, 2025
    Circular Genomics announced Series A of $15,000,000, led by Mountain Group Partners
    Round announced Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
  2. Jan 23, 2024
    Circular Genomics Inc. filed Form D: $8,300,000 sold of $15,000,000, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
16 observations
Every observation on this company